Verapamil Hydrochloride

ANDA 70451, held by Intl Medication. Verapamil Hydrochloride.

As of Nov 15, 2026, ANDA 70451 (Verapamil Hydrochloride), held by Intl Medication, was first approved by FDA on Dec 16, 1985, with 7 approved supplements and 0 published complete response letters.

First approved: Dec 16, 1985
Supplements approved: 7
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 8 submissions below

Date	Submission	Status	Documents
Dec 16, 1985	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Verapamil Hydrochloride2.5MG/ML · injectable;injection	Verapamil Hydrochloride	Discontinued

All 8 submissions, including labeling and manufacturing supplements


Jan 14, 1998	Supplement 8Manufacturing	Approved	None posted
Sep 19, 1995	Supplement 11Manufacturing	Approved	None posted
Jun 17, 1994	Supplement 9Manufacturing	Approved	None posted
Oct 29, 1993	Supplement 7Manufacturing	Approved	None posted
Jan 9, 1992	Supplement 6Labeling	Approved	None posted
Jun 24, 1991	Supplement 5Labeling	Approved	None posted
Apr 16, 1987	Supplement 1Manufacturing	Approved	None posted
Dec 16, 1985	Original application	Approved	None posted

Identifiers

Application: ANDA 70451
Drugs@FDA: Overview at FDA
Company: International Medication Systems

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters